FDA Clearance Tracker · K192515
BIOEASY Marijuana Test Dip Card 40, BIOEASY Marijuana Test Dip Card 20, BIOEASY Marijuana Test Strip 40, BIOEASY Marijuana Test Strip 20
Last checked: Nov 19, 2026Latest source record: Oct 11, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Oct 11, 2019
Substantially Equivalent
Time to decision
28 days
Received Sep 13, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K192515
- Device name
- BIOEASY Marijuana Test Dip Card 40, BIOEASY Marijuana Test Dip Card 20, BIOEASY Marijuana Test Strip 40, BIOEASY Marijuana Test Strip 20
- Applicant location
- Shenzhen, CN
- Received
- Sep 13, 2019
- Decided
- Oct 11, 2019
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Enzyme Immunoassay, Cannabinoids (LDJ)
- Device class
- Class II
- Regulation
- 21 CFR 862.3870
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LDJ. The earliest in FDA's data is K812195, decided Aug 20, 1981.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K192515
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Shenzhen Bioeasy Biotechnology Co., Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K230238 · Decided Mar 31, 2023 · 60 days after receipt
Device type: Enzyme Immunoassay, Opiates (DJG) · Laboratory Medicine & Pathology
K193480 · Decided Jan 31, 2020 · 46 days after receipt
Device type: Test, Opiates, Over The Counter (NGL) · Laboratory Medicine & Pathology
K192301 · Decided Sep 20, 2019 · 28 days after receipt
Device type: Test, Cannabinoid, Over The Counter (NFW) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.